Association of the -183 polymorphism in the IFN-γ gene promoter with hepatitis B virus infection in the Chinese population

Journal of Clinical Laboratory Analysis

Volumn 19, Issue 6, 2005, Pages 276-281

  Qi, Suxia ^a,b   Cao, Bangwei ^c,d   Jiang, Mingwei ^d   Xu, Changqing ^b   Dai, Yue ^c   Li, Kun ^b   Wang, Kun ^a,b   Ke, Yang ^e   Ning, Tao ^e  

^a SHANDONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

^d First People's Hospital of Xuzhou   (China)

^e PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Hepatitis B virus; IFN ; Polymorphism; Promoter; Susceptibility

Indexed keywords

GAMMA INTERFERON; TRANSCRIPTION FACTOR AP 1;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENETIC RISK; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; CHINA; FEMALE; GENOTYPE; HEPATITIS B; HUMANS; INTERFERON TYPE II; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SEX FACTORS;

HEPATITIS B VIRUS;

EID: 28444452954     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.20090     Document Type: Article

References (23)

1. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003;9:641-644.
2. Maddrey WC. Hepatitis B-an important public health issue. Clin Lab 2001;47:51-55.
3. Gu CH, Luo KX, editors. "Hepatitis B: basic biology and clinical science." 2nd ed. Beijing: People's Medical Publishing House; 2001.
4. Echevarria JM, Leon P. Epidemiology of viruses causing chronic hepatitis among populations from the Amazon Basin and related ecosystems. Cad Saude Publica 2003;19:1583-1591.
5. Ferrari C, Penna A, Bertoletti A. et al. Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections. Recent Results Cancer Res 1998;154:330-336.
6. Ho LJ, Shaio MF, Chang DM, Liao CL, Lai JH. Infection of human dendritic cells by dengue virus activates and primes T cells towards Th0-like phenotype producing both Th1 and Th2 cytokines. Immunol Invest 2004;33:423-437.
7. Bucheton B, Abel L, Kheir MM, et al. Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immunol 2003;4:104-109.
8. Krishnan V, Zeichner SL. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency. J Virol 2004;78:9458-9473.
9. Nakamoto Y, Kaneko S. Mechanisms of viral hepatitis induced liver injury. Curr Mol Med 2003;3:537-544.
10. Ortiz GC, Sheridan JF, Marucha PT. Stress-induced changes in pathophysiology and interferon gene expression during primary HSV-1 infection. Brain Behav Immunol 2003;17:329-338.
11. Sato S, Kawashima H, Oshiro H, et al. Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Virol 2004;31:235-238.
12. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993;259:1739-1742.
13. An P, Vlahov D, Margolick JB, et al. A tumor necrosis factor-alpha inducible promoter variant of interferon-gamma accelerates CD4+T cell depletion in human immunodeficiency virus-1-infected individuals. J Infect Dis 2003;188:228-231.
14. Ben-Ari Z, Pappo O, Druzd T, et al. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation. Cytokine 2004;27:7-14.
15. Kojima H, Aizawa Y, Yanai Y, et al. An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells. J Immunol 1999;162:5063-5069.
16. Chevillard C, Moukoko CE, Elwali NE, et al. IFN-gamma polymorphisms (IFN-gamma+2109 and IFN-gamma+3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol 2003;171:5596-5601.
17. Chevillard C, Henri S, Stefani F, Parzy D, Dessein A. Two new polymorphisms in the human interferon gamma (IFN-gamma) promoter. Eur J Immunogenet 2002;29:53-56.
18. Barbulescu K, Meyer zum Buschenfelde KH, Neurath MF. Constitutive and inducible protein/DNA interactions of the interferon-gamma promoter in vivo in [corrected] CD45RA and CD45RO T helper subsets. Eur J Immunol 1997;27:1098-1107.
19. Li Z, Chen D, Zhang C, et al. HLA polymorphisms are associated with Helicobacter pylori infected gastric cancer in a high risk population, China. Immunogenetics 2005;56:781-787.
20. Iino S. Natural history of hepatitis B and C virus infections. Oncology 2002;62:18-23.
21. Lio D, Scola L, Crivello A, et al. Allele frequencies of +874T→A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians. Exp Gerontol 2002;37:315-319.
22. Bream JH, Ping A, Zhang X, Winkler C, Young HA. A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription. Genes Immunol 2002;3:165-169.
23. Kaminuma O, Kitamura F, Kitamura N, et al. GATA-3 suppresses IFN-gamma promoter activity independently of binding to cis-regulatory elements. FEBS Lett 2004;570:63-68.